Pulmonary Hypertension Prevalence and Prognosis in a Cohort of Patients with Hereditary Hemorrhagic Telangiectasia Undergoing Embolization of Pulmonary Arteriovenous Malformations

Authors

Mwelwa Chizinga, 1 Yale-New Haven Hospital New Haven, Connecticut.
Anastasiia A. Rudkovskaia, 3 Yale University School of Medicine New Haven, Connecticut and.
Katharine Henderson, 1 Yale-New Haven Hospital New Haven, Connecticut.
Jeffrey Pollak, 1 Yale-New Haven Hospital New Haven, Connecticut.
Guadalupe Garcia-Tsao, 1 Yale-New Haven Hospital New Haven, Connecticut.
Lawrence H. Young, 1 Yale-New Haven Hospital New Haven, Connecticut.
Wassim H. Fares, 3 Yale University School of Medicine New Haven, Connecticut and.

Document Type

Article

Publication Title

American journal of respiratory and critical care medicine

First Page

1353

Last Page

1356

DOI

10.1164/rccm.201702-0267LE

Publication Date

11-15-2017

Recommended Citation

Chizinga, Mwelwa; Rudkovskaia, Anastasiia A.; Henderson, Katharine; Pollak, Jeffrey; Garcia-Tsao, Guadalupe; Young, Lawrence H.; and Fares, Wassim H., "Pulmonary Hypertension Prevalence and Prognosis in a Cohort of Patients with Hereditary Hemorrhagic Telangiectasia Undergoing Embolization of Pulmonary Arteriovenous Malformations" (2017). All Research. 234.
https://scholar.bridgeporthospital.org/all_research/234

Identifier

28375020 (pubmed); 10.1164/rccm.201702-0267LE (doi)